leisure time -WSS

leisure time

author：leisure time 2025-09-28 22:53:36 - browse：361

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Cancer drug shortages should be causing more outrage

WSS

After affirmative action ruling, medical educators look to 'holistic review'

Winning ticket for $1 billion Powerball jackpot sold in California

Ending racial health disparities hinges on penalties, political will

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Why Congress must ban federal programs from using QALYs

Stanford president faces new allegations over 1999 paper

entertainment

leisure time

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Virginia high school admissions case could be legal follow

Virginia high school admissions case could be legal follow

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

In Memoriam: Notable people who died in 2023

Why Congress must ban federal programs from using QALYs

Wildfire smoke exposes gaps in outdoor worker protections

Study identifies new proteins linked to dementia risk 25 years later

State Dept. review finds Biden bears some blame for Afghanistan failures

I learned firsthand about improving diversity in clinical trials

focus

Duchenne breakthrough therapy leaves behind pioneering families

Virginia high school admissions case could be legal follow

Drug repurposing or repositioning? The language matters

Hospitals struggle to profit from CAR

Trump demands the U.S. pay no more for drugs than other countries … again

EF3 tornado rips through North Carolina amid extreme weather nationwide

entertainment

hotspot

knowledge

leisure time